These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 11858909)

  • 1. Antimicrobial susceptibilities of Streptococcus pyogenes isolated from respiratory and skin and soft tissue infections: United States LIBRA surveillance data from 1999.
    Critchley IA; Sahm DF; Thornsberry C; Blosser-Middleton RS; Jones ME; Karlowsky JA
    Diagn Microbiol Infect Dis; 2002 Feb; 42(2):129-35. PubMed ID: 11858909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrolide-resistant genes of Streptococcus pyogenes isolated from the upper respiratory tract by polymerase chain reaction.
    Billal DS; Hotomi M; Yamauchi K; Fujihara K; Tamura S; Kuki K; Sugita R; Endou M; Mukaigawa J; Yamanaka N
    J Infect Chemother; 2004 Apr; 10(2):115-20. PubMed ID: 15160306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [In vitro susceptibility of respiratory isolates of Streptococcus pneumoniae and Streptococcus pyogenes to telithromycin and 11 other antimicrobial agents: Turkish results of e-BASKETT-II surveillance study].
    Gür D; Mülazimoğlu L; Unal S;
    Mikrobiyol Bul; 2007 Jan; 41(1):1-9. PubMed ID: 17427547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial susceptibility of Streptococcus pneumoniae, Streptococcus pyogenes and Haemophilus influenzae collected from patients across the USA, in 2001-2002, as part of the PROTEKT US study.
    Brown SD; Rybak MJ
    J Antimicrob Chemother; 2004 Aug; 54 Suppl 1():i7-15. PubMed ID: 15265831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telithromycin and quinupristin-dalfopristin resistance in clinical isolates of Streptococcus pyogenes: SMART Program 2001 Data.
    Hsueh PR; Teng LJ; Lee CM; Huang WK; Wu TL; Wan JH; Yang D; Shyr JM; Chuang YC; Yan JJ; Lu JJ; Wu JJ; Ko WC; Chang FY; Yang YC; Lau YJ; Liu YC; Leu HS; Liu CY; Luh KT;
    Antimicrob Agents Chemother; 2003 Jul; 47(7):2152-7. PubMed ID: 12821461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current status of antimicrobial susceptibility of clinical isolates of Streptococcus pyogenes in Japan: report of a countrywide surveillance study.
    Hotomi M; Billal DS; Shimada J; Yamauchi K; Fujihara K; Yamanaka N;
    J Infect Chemother; 2005 Feb; 11(1):48-51. PubMed ID: 15729489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro antimicrobial activity of ozenoxacin against methicillin-susceptible Staphylococcus aureus, methicillin-resistant S. aureus and Streptococcus pyogenes isolated from clinical cutaneous specimens in Japan.
    Kanayama S; Ikeda F; Okamoto K; Nakajima A; Matsumoto T; Ishii R; Amano A; Matsuzaki K; Matsumoto S
    J Infect Chemother; 2016 Oct; 22(10):720-3. PubMed ID: 27091753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emergence of high-level fluoroquinolone resistance in emm6 Streptococcus pyogenes and in vitro resistance selection with ciprofloxacin, levofloxacin and moxifloxacin.
    Malhotra-Kumar S; Van Heirstraeten L; Lammens C; Chapelle S; Goossens H
    J Antimicrob Chemother; 2009 May; 63(5):886-94. PubMed ID: 19279051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. National surveillance programme on susceptibility patterns of respiratory pathogens in South Africa: moxifloxacin compared with eight other antimicrobial agents.
    Liebowitz LD; Slabbert M; Huisamen A
    J Clin Pathol; 2003 May; 56(5):344-7. PubMed ID: 12719453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial susceptibilities of Streptococcus pyogenes isolated from adult patients with respiratory tract and skin and soft tissue infections in four southern European countries.
    Soriano F; Granizo JJ; Fernández-Roblas R; Esteban J; Gadea I; Gracia M; Coronel P; Gimeno M; Ródenas E
    J Chemother; 2003 Jun; 15(3):293-5. PubMed ID: 12868559
    [No Abstract]   [Full Text] [Related]  

  • 11. Antimicrobial susceptibilities of 1,684 Streptococcus pneumoniae and 2,039 Streptococcus pyogenes isolates and their ecological relationships: results of a 1-year (1998-1999) multicenter surveillance study in Spain.
    Pérez-Trallero E; Fernández-Mazarrasa C; García-Rey C; Bouza E; Aguilar L; García-de-Lomas J; Baquero F;
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3334-40. PubMed ID: 11709305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rates of antimicrobial resistance among common bacterial pathogens causing respiratory, blood, urine, and skin and soft tissue infections in pediatric patients.
    Jones ME; Karlowsky JA; Draghi DC; Thornsberry C; Sahm DF; Bradley JS
    Eur J Clin Microbiol Infect Dis; 2004 Jun; 23(6):445-55. PubMed ID: 15156358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrolide-resistant Streptococcus pyogenes in the United States, 2002-2003.
    Richter SS; Heilmann KP; Beekmann SE; Miller NJ; Miller AL; Rice CL; Doern CD; Reid SD; Doern GV
    Clin Infect Dis; 2005 Sep; 41(5):599-608. PubMed ID: 16080080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic susceptibility in Streptococcus pneumoniae, Haemophilus influenzae and Streptococcus pyogenes in Pakistan: a review of results from the Survey of Antibiotic Resistance (SOAR) 2002-15.
    Zafar A; Hasan R; Nizamuddin S; Mahmood N; Mukhtar S; Ali F; Morrissey I; Barker K; Torumkuney D
    J Antimicrob Chemother; 2016 May; 71 Suppl 1(Suppl 1):i103-9. PubMed ID: 27048578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral antimicrobial susceptibilities of Streptococcus pyogenes recently isolated in five countries.
    Bandak SI; Turnak MR; Allen BS; Bolzon LD; Preston DA
    Int J Clin Pract; 2000 Nov; 54(9):585-8. PubMed ID: 11220986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular characterization of macrolide resistance mechanisms among Streptococcus pneumoniae and Streptococcus pyogenes isolated from the PROTEKT 1999-2000 study.
    Farrell DJ; Morrissey I; Bakker S; Felmingham D
    J Antimicrob Chemother; 2002 Sep; 50 Suppl S1():39-47. PubMed ID: 12239227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial susceptibility among community-acquired respiratory tract pathogens in the USA: data from PROTEKT US 2000-01.
    Doern GV; Brown SD
    J Infect; 2004 Jan; 48(1):56-65. PubMed ID: 14667792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of several antimicrobial agents against 1003 isolates of Streptococcus pyogenes collected from Western Canada.
    Blondeau JM; Church D; Yaschuk Y; Bjarnason J
    Int J Antimicrob Agents; 1999 Jun; 12(1):67-70. PubMed ID: 10389650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial activity of ceftaroline and comparator agents tested against bacterial isolates causing skin and soft tissue infections and community-acquired respiratory tract infections isolated from the Asia-Pacific region and South Africa (2010).
    Sader HS; Flamm RK; Jones RN
    Diagn Microbiol Infect Dis; 2013 May; 76(1):61-8. PubMed ID: 23535208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ceftaroline activity tested against bacterial isolates from pediatric patients: results from the assessing worldwide antimicrobial resistance and evaluation program for the United States (2011-2012).
    Sader HS; Mendes RE; Farrell DJ; Flamm RK; Jones RN
    Pediatr Infect Dis J; 2014 Aug; 33(8):837-42. PubMed ID: 25222304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.